![]() |
| Imaging of Behavioral Variant Frontotemporal Dementia (bvFTD) Image: © Bradford Dickerson |
This research project is looking at whether the trial drug, sodium selenate, decreases the rate of brain shrinkage in patients with bvFTD.
Participants are randomly assigned to one of two groups. One group will receive the study drug, sodium selenate, and the other group will receive a placebo.
